INTERNATIONAL PATENT: GIGAGEN, INC. FILES APPLICATION FOR "RECOMBINANT POLYCLONAL PROTEINS TARGETING HEPATITIS B VIRUS (HBV) AND METHODS OF USE THEREOF"

GENEVA, Feb. 26 -- GIGAGEN, INC. (75 Shoreway Road, Suite ASan Carlos, CA 94070) filed a patent application (PCT/US2024/042286) for "RECOMBINANT POLYCLONAL PROTEINS TARGETING HEPATITIS B VIRUS (HBV) AND METHODS OF USE THEREOF" on Aug 14, 2024. With publication no. WO/2025/038732, the details related to the patent application was published on Feb 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ADLER, Adam, Shultz (GigaGen, Inc.75 Shoreway Road, Suite ASan Carlos, CA 94070), KEATING, Sheila (GigaGen, Inc.75 Shoreway Road, Suite ASan Carlos, CA 94070), MIZRAHI, Rena, Aviva (GigaGen, Inc.75 ...